BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25859633)

  • 1. Deep brain stimulation in the globus pallidus compensates response inhibition deficits: evidence from pantothenate kinase-associated neurodegeneration.
    Mückschel M; Smitka M; Hermann A; von der Hagen M; Beste C
    Brain Struct Funct; 2016 May; 221(4):2251-7. PubMed ID: 25859633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in children with pantothenate-kinase-associated neurodegeneration undergoing deep brain stimulation.
    Mahoney R; Selway R; Lin JP
    Dev Med Child Neurol; 2011 Mar; 53(3):275-9. PubMed ID: 21166667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pallidal stimulation for pantothenate kinase-associated neurodegeneration dystonia.
    Isaac C; Wright I; Bhattacharyya D; Baxter P; Rowe J
    Arch Dis Child; 2008 Mar; 93(3):239-40. PubMed ID: 18319387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation.
    Lim BC; Ki CS; Cho A; Hwang H; Kim KJ; Hwang YS; Kim YE; Yun JY; Jeon BS; Lim YH; Paek SH; Chae JH
    Eur J Neurol; 2012 Apr; 19(4):556-61. PubMed ID: 22103354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pallidal stimulation in siblings with pantothenate kinase-associated neurodegeneration: four-year follow-up.
    Adamovicová M; Jech R; Urgošík D; Spacková N; Krepelová A
    Mov Disord; 2011 Jan; 26(1):184-7. PubMed ID: 20848620
    [No Abstract]   [Full Text] [Related]  

  • 6. Deep brain stimulation as treatment for dystonic storm in pantothenate kinase-associated neurodegeneration syndrome: case report of a patient with homozygous C.628 2 T > G mutation of the PANK2 gene.
    Tanrıkulu B; Özen A; Günal DI; Türkdoğan D; Bayraklı F; Bayri Y; Dağçınar A; Şeker A
    Acta Neurochir (Wien); 2015 Sep; 157(9):1513-6; discussion 1516-7. PubMed ID: 26223911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration.
    Mikati MA; Yehya A; Darwish H; Karam P; Comair Y
    Eur J Paediatr Neurol; 2009 Jan; 13(1):61-4. PubMed ID: 18462962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantothenate kinase-associated neurodegeneration.
    Hundallah K; Al Hakeem A
    Neurosciences (Riyadh); 2017 Apr; 22(2):156-157. PubMed ID: 28416789
    [No Abstract]   [Full Text] [Related]  

  • 9. Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration.
    Lee JH; Gregory A; Hogarth P; Rogers C; Hayflick SJ
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):583-588. PubMed ID: 29371252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration.
    Castelnau P; Cif L; Valente EM; Vayssiere N; Hemm S; Gannau A; Digiorgio A; Coubes P
    Ann Neurol; 2005 May; 57(5):738-41. PubMed ID: 15852393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation in the management of pantothenate kinase-associated neurodegeneration: a missed or a new target?
    Jabre MG; Nohra G; Bejjani BP
    Eur J Paediatr Neurol; 2010 May; 14(3):290-1. PubMed ID: 19709916
    [No Abstract]   [Full Text] [Related]  

  • 12. Pallidal stimulation for dystonia in pantothenate kinase-associated neurodegeneration.
    Shields DC; Sharma N; Gale JT; Eskandar EN
    Pediatr Neurol; 2007 Dec; 37(6):442-5. PubMed ID: 18021929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurophysiological evidence for the enhancement of cognitive control under dorsal pallidal deep brain stimulation in Huntington's disease.
    Beste C; Mückschel M; Elben S; J Hartmann C; McIntyre CC; Saft C; Vesper J; Schnitzler A; Wojtecki L
    Brain Struct Funct; 2015 Jul; 220(4):2441-8. PubMed ID: 24878825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time.
    Fermin-Delgado R; Roa-Sanchez P; Speckter H; Perez-Then E; Rivera-Mejia D; Foerster B; Stoeter P
    Clin Neuroradiol; 2013 Mar; 23(1):11-5. PubMed ID: 22258188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia calcification in a case of PKAN.
    Fasano A; Shahidi G; Lang AE; Rohani M
    Parkinsonism Relat Disord; 2017 Mar; 36():98-99. PubMed ID: 28024710
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of human internal globus pallidus in the early modulation of cortical error-related activity.
    Herrojo Ruiz M; Huebl J; Schönecker T; Kupsch A; Yarrow K; Krauss JK; Schneider GH; Kühn AA
    Cereb Cortex; 2014 Jun; 24(6):1502-17. PubMed ID: 23349222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status dystonicus in pantothenate kinase-associated neurodegeneration due to internal pulse generator depletion: Case study and literature review.
    Li H; Zhang C; Pan Y; Sun B; Li D; Wu Y
    J Neurol Sci; 2019 May; 400():44-46. PubMed ID: 30903858
    [No Abstract]   [Full Text] [Related]  

  • 18. Idiopathic basal ganglia calcifications: an atypical presentation of PKAN.
    Wu YW; Hess CP; Singhal NS; Groden C; Toro C
    Pediatr Neurol; 2013 Nov; 49(5):351-4. PubMed ID: 23968566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation of the globus pallidus suppresses post-traumatic dystonic tremor.
    Carvalho KS; Sukul VV; Bookland MJ; Koch SA; Connolly PJ
    J Clin Neurosci; 2014 Jan; 21(1):153-5. PubMed ID: 23896546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients.
    Dezortova M; Herynek V; Krssak M; Kronerwetter C; Trattnig S; Hajek M
    Contrast Media Mol Imaging; 2012; 7(6):509-15. PubMed ID: 22991317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.